Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Deloitte
Boehringer Ingelheim
Moodys
McKinsey
Queensland Health
Cerilliant
Healthtrust
Daiichi Sankyo

Generated: February 18, 2019

DrugPatentWatch Database Preview

TYSABRI Drug Profile

« Back to Dashboard

Summary for Tradename: TYSABRI
Pharmacology for TYSABRI
Mechanism of ActionIntegrin Receptor Antagonists

US Patents for TYSABRI

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial Pathologica LLC (San Francisco, CA) ➤ Try a Free Trial RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial CureVac AG (Tubingen, DE) ➤ Try a Free Trial RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial Biogen MA Inc. (Cambridge, MA) ➤ Try a Free Trial RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial University of Iowa Research Foundation (Oakdale, IA) ➤ Try a Free Trial RX company
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial University of Iowa Research Foundation (Iowa City, IA) ➤ Try a Free Trial RX company
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial Fred Hutchinson Cancer Research Center (Seattle, WA) ➤ Try a Free Trial RX company
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial Athena Neurosciences, Inc. (South San Francisco, CA) ➤ Try a Free Trial RX company
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for TYSABRI

Supplementary Protection Certificates for TYSABRI

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
122006000043 Germany ➤ Try a Free Trial PRODUCT NAME: NATALIZUMAB; NAT. REGISTRATION NO/DATE: EU /1/06/346/001 20060627; FIRST REGISTRATION: EU EU/1/06/346/001 20060627
LUC00065 Luxembourg ➤ Try a Free Trial PRODUCT NAME: CLADRIBINE; AUTHORISATION NUMBER AND DATE: EU/1/17/1212 20170824
91271 Luxembourg ➤ Try a Free Trial 91271, EXPIRES: 20200125
C300238 Netherlands ➤ Try a Free Trial PRODUCT NAME: NATALIZUMAB; REGISTRATION NO/DATE: EU/1/06/346/001 20060627
SZ 23/2006 Austria ➤ Try a Free Trial PRODUCT NAME: NATALIZUMAB
300240 Netherlands ➤ Try a Free Trial PRODUCT: NATALIZUMAB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; FIRST REGISTRATION, DATE: EU/1/06/346/001, 20060627
C00804237/01 Switzerland ➤ Try a Free Trial FORMER OWNER: ELAN PHARMACEUTICALS, INC., US
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Julphar
Farmers Insurance
Cerilliant
Queensland Health
Fuji
Boehringer Ingelheim
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.